Total Payments
$658.29
2023 Payments
$125.00
Companies
5
Transactions
21
Medicare Patients
3,861
Medicare Billing
$407,063
Payment Breakdown by Category
Food & Beverage$642.90 (97.7%)
Education$15.39 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $642.90 | 19 | 97.7% |
| Education | $15.39 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $570.31 | 15 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $42.16 | 3 | $0 (2017) |
| Lantheus Medical Imaging, Inc. | $19.71 | 1 | $0 (2017) |
| EMD Serono, Inc. | $13.41 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $125.00 | 1 | GlaxoSmithKline, LLC. ($125.00) |
| 2022 | $121.82 | 1 | GlaxoSmithKline, LLC. ($121.82) |
| 2021 | $143.57 | 4 | GlaxoSmithKline, LLC. ($143.57) |
| 2019 | $167.54 | 8 | GlaxoSmithKline, LLC. ($154.84) |
| 2018 | $13.04 | 1 | GlaxoSmithKline, LLC. ($13.04) |
| 2017 | $87.32 | 6 | Sunovion Pharmaceuticals Inc. ($42.16) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $96.24 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2017 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Contrast Agent | ||||||
| 08/07/2017 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | Cash or cash equivalent | $13.41 | General |
| Category: Oncology | ||||||
| 04/17/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,012 | 1,455 | $184,485 | $95,235 |
| 2022 | 18 | 1,105 | 1,535 | $200,431 | $112,185 |
| 2021 | 17 | 981 | 1,393 | $194,871 | $111,113 |
| 2020 | 14 | 763 | 1,127 | $151,819 | $88,530 |
Total Patients
3,861
Total Services
5,510
Medicare Billing
$407,063
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 197 | 510 | $52,252 | $32,598 | 62.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 232 | $40,600 | $23,031 | 56.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 152 | 177 | $35,616 | $18,667 | 52.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 65 | $8,678 | $6,274 | 72.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,840 | $3,206 | 46.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $5,500 | $3,094 | 56.3% |
| 32554 | Aspiration of fluid from chest cavity | Facility | 2023 | 21 | 29 | $4,450 | $2,023 | 45.5% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 13 | 13 | $4,824 | $1,330 | 27.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 92 | 92 | $4,710 | $844.61 | 17.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 24 | 24 | $4,350 | $838.08 | 19.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 96 | 96 | $3,660 | $765.75 | 20.9% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 14 | 14 | $5,400 | $762.93 | 14.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 109 | 109 | $5,510 | $751.80 | 13.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 12 | $636.00 | $489.00 | 76.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 11 | 11 | $814.00 | $401.94 | 49.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 25 | 25 | $645.00 | $156.96 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 221 | 470 | $45,962 | $27,271 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 224 | $32,480 | $22,123 | 68.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 169 | 187 | $33,348 | $20,623 | 61.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 149 | $19,948 | $12,334 | 61.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 37 | $11,359 | $6,655 | 58.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 35 | $7,000 | $4,915 | 70.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $6,165 | $3,942 | 63.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $4,800 | $3,172 | 66.1% |
| 32554 | Aspiration of fluid from chest cavity | Facility | 2022 | 23 | 40 | $12,300 | $2,853 | 23.2% |
About Dr. Michael Gamiao, MD
Dr. Michael Gamiao, MD is a Specialist healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134179880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gamiao, MD has received a total of $658.29 in payments from pharmaceutical and medical device companies, with $125.00 received in 2023. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($642.90).
As a Medicare-enrolled provider, Gamiao has provided services to 3,861 Medicare beneficiaries, totaling 5,510 services with total Medicare billing of $407,063. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Pulmonary Disease
- Location Livonia, MI
- Active Since 05/12/2006
- Last Updated 04/02/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1134179880
Products in Payments
- TRELEGY ELLIPTA (Drug) $393.11
- AREXVY (Drug) $125.00
- NUCALA (Biological) $40.16
- UTIBRON (Drug) $21.62
- BROVANA (Drug) $20.54
- Definity (Drug) $19.71
- Bavencio (Biological) $13.41
- ZERBAXA (Drug) $12.70
- ANORO (Drug) $12.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Livonia
Dr. Nasser Taghavi, M.d, M.D
Specialist — Payments: $4,654
Specialist $4,654
Dr. Jay Nathan, Md, MD
Specialist — Payments: $4,194
Specialist $4,194
Dr. Dipti Shah, M.d, M.D
Specialist — Payments: $1,063
Specialist $1,063
Amit Mohindra, M.d, M.D
Specialist — Payments: $816.47
Specialist $816.47
Dr. Mohammad Yousuf, Md, MD
Specialist — Payments: $540.69
Specialist $540.69
Dr. Ramesh Mohindra, Md, MD
Specialist — Payments: $470.57
Specialist $470.57